VSee Health Inc. Reports 81% Increase in Revenue for 2024, Net Loss Widens Significantly to $57.7 Million

Reuters
2025/08/29
<a href="https://laohu8.com/S/VSEE">VSee Health</a> Inc. Reports 81% Increase in Revenue for 2024, Net Loss Widens Significantly to $57.7 Million

VSee Health Inc. reported significant financial results for the fiscal year ending December 31, 2024. The company achieved revenues of $10.4 million, representing an 81% increase compared to $5.8 million in 2023. Despite this growth in revenue, VSee Health recorded a net loss of $57.7 million, a substantial increase from the net loss of $3.7 million in the prior year. The gross margin for VSee Health rose to $7.2 million, up from $3.8 million the previous year, marking an 87% improvement. Operating expenses soared to $69.3 million from $5.7 million, a significant rise that impacted the company's bottom line. In terms of other income and expenses, VSee Health reported a net gain of $2.8 million compared to a slight loss of $13,375 in the prior year. The company also noted an income tax benefit of $1.6 million, contrasting with a provision of $1.8 million the year before. Business operations continue to focus on generating revenue through subscription services to its software platform via its subsidiary, VSee Lab. The company has adjusted its financial statements, reflecting restatement adjustments in its financial analysis.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VSee Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001558370-25-011813), on August 28, 2025, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10